Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.7065
-0.0357 (-4.81%)
At close: Oct 30, 2026, 4:00 PM EDT
0.7000
-0.0065 (-0.92%)
After-hours: Oct 30, 2026, 7:29 PM EDT
AKBA's stock price has decreased by -66.36% in the past year and price targets may not have had time to catch up.
Akebia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $4 | Buy | Maintains | $4 | +466.17% | Oct 21, 2026 |
| BTIG | BTIG | Buy Maintains $4 | Buy | Maintains | $4 | +466.17% | Sep 15, 2026 |
| Westpark Capital | Westpark Capital | Buy Initiates $4.5 | Buy | Initiates | $4.5 | +536.94% | Sep 8, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $1 | Hold | Downgrades | $1 | +41.54% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +749.26% | Aug 6, 2026 |